Cyf Ramos-Colón received her PhD in Pharmaceutical Sciences in 2016 from the University of Arizona College of Pharmacy. She worked with Victor J. Hruby in the design and development of novel peptide drugs based on endogenous opioid peptides for the treatment of opiate related side effects. In 2016 she joined the Gyros Protein Technologies team where she has led the Peptide Applications laboratory, developing peptide synthesis applications on automated peptide synthesizers exploring new synthetic approaches.